{
    "Trade/Device Name(s)": [
        "Elecsys CYFRA 21-1 CalCheck 5"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K162173",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150955"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "December 15, 2016",
    "Summary Letter Received Date": "December 16, 2016",
    "Submission Date": "June 30, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cytokeratin (CYFRA 21-1)"
    ],
    "Specimen Type(s)": [
        "Human serum matrix"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010 analyzer",
        "cobas e 411 analyzer",
        "MODULAR ANALYTICS E170 analyzer",
        "cobas e 601 analyzer",
        "cobas e 602 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys CYFRA 21-1 CalCheck 5, an assayed control for calibration verification on Elecsys and cobas e immunoassay analyzers.",
    "Indications for Use Summary": "Assayed control for use in calibration verification and verification of assay range established by Elecsys CYFRA 21-1 reagent on indicated Elecsys and cobas e immunoassay analyzers.",
    "fda_folder": "Clinical Chemistry"
}